The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Ishares Msci Italy Index Fund

NYSE: EWI
Last

(U.S.) $15.01

Today's change+0.17 +1.15%
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Ishares Msci Italy Index Fund

NYSE: EWI
Last

(U.S.) $15.01

Today's change+0.17 +1.15%
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Ishares Msci Italy Index Fund up (U.S.)$0.17

Ishares Msci Italy Index Fund closed up Thursday by (U.S.)$0.17 or 1.15% to (U.S.)$15.01. Over the last five days, shares have gained 0.81% and 10.37% year to date. Shares have underperformed the S&P 500 by 6.89% during the last year.

Key company metrics

  • Open(U.S.) $14.86
  • Previous close(U.S.) $14.84
  • High(U.S.) $15.03
  • Low(U.S.) $14.82
  • Bid / Ask-- / --
  • YTD % change+10.37%
  • Volume7,536,464
  • Average volume (10-day)2,615,215
  • Average volume (1-month)2,190,857
  • Average volume (3-month)2,371,129
  • 52-week range(U.S.) $12.71 to (U.S.) $16.52
  • Beta1.42
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.37
  • Dividend yield2.48%
  • Trailing EPS(U.S.) -$2.46
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-553.49%

Ishares Msci Italy Index Fund has a net profit margin of -553.49%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.88%Sector:FinancialsIndustry:Investment Trusts
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue829714
Total other revenue--------
Total revenue829714
Gross profit525513
Total cost of revenue3422
Total operating expense3422
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income525513
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-101-10320934
Income after tax-101-10320934
Income tax, total0000
Net income-101-10320934
Total adjustments to net income--------
Net income before extra. items-101-10320934
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-101-10320934
Inc. avail. to common incl. extra. items-101-10320934
Diluted net income-101-10320934
Dilution adjustment--------
Diluted weighted average shares611286766
Diluted EPS excluding extraordinary itemsvalue per share-1.65-0.813.120.52
Dividends per sharevalue per share0.100.240.100.25
Diluted normalized EPSvalue per share-1.65-0.813.120.52